Authors: Thingstad, T Vos, HL Hilkens, J

Citation: T. Thingstad et al., Biosynthesis and shedding of epiglycanin: a mucin-type glycoprotein of themouse TA3Ha mammary carcinoma cell, BIOCHEM J, 353, 2001, pp. 33-40

Authors: Gaemers, IC Vos, HL Volders, HH van der Valk, SW Hilkens, J

Citation: Ic. Gaemers et al., A STAT-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells, J BIOL CHEM, 276(9), 2001, pp. 6191-6199

Authors: Steelant, WFA Goeman, JL Philippe, J Oomen, LCJM Hilkens, J Krzewinski-Recchi, MA Huet, G Van der Eycken, J Delannoy, P Bruyneel, EA Mareel, MM

Citation: Wfa. Steelant et al., Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl-glycerophosphocholine induces invasion through epislalin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro, INT J CANC, 92(4), 2001, pp. 527-536

Authors: Hilkens, J Bonfrer, H

Citation: J. Hilkens et H. Bonfrer, Diagnosis and monitoring of bone metastases: Serum tumor markers, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 197-212

Authors: DeSouza, MM Surveyor, GA Price, RE Julian, J Kardon, R Zhou, XH Gendler, S Hilkens, J Carson, DD

Citation: Mm. Desouza et al., MUC1/episialin: a critical barrier in the female reproductive tract, J REPRO IMM, 45(2), 1999, pp. 127-158